Quantbot Technologies LP Acquires New Position in agilon health, inc. (NYSE:AGL)

Quantbot Technologies LP acquired a new position in shares of agilon health, inc. (NYSE:AGLFree Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 443,305 shares of the company’s stock, valued at approximately $1,742,000.

A number of other institutional investors also recently bought and sold shares of the company. J.Safra Asset Management Corp increased its holdings in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the last quarter. City State Bank purchased a new stake in agilon health in the third quarter valued at $52,000. CWM LLC lifted its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC purchased a new position in shares of agilon health during the 2nd quarter worth $60,000. Finally, Allspring Global Investments Holdings LLC increased its position in shares of agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares during the last quarter.

Insider Activity at agilon health

In other news, CEO Steven Sell purchased 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.20% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Stifel Nicolaus lowered their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. Finally, William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, agilon health currently has an average rating of “Hold” and a consensus target price of $6.05.

Check Out Our Latest Analysis on agilon health

agilon health Stock Performance

NYSE:AGL opened at $2.10 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $13.76. The firm has a market capitalization of $865.24 million, a PE ratio of -2.23 and a beta of 0.60. The business’s fifty day moving average price is $2.76 and its 200 day moving average price is $4.66.

agilon health (NYSE:AGLGet Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the company earned ($0.06) earnings per share. On average, sell-side analysts anticipate that agilon health, inc. will post -0.47 earnings per share for the current fiscal year.

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.